VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Aspirin Challenge
Phase 2
Small molecule
R
Rush University Medical Center
1
Indications
2
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Respiratory Disease
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Respiratory Disease
Phase 2
Recruiting
Clinical
Trials by Indication
[1]
Liver Disease
1 trial
Alcohol, Gut Leakiness, & Liver Disease
Completed
·
R
Rush University Medical Center
·
Phase 1
·
NCT05428072
·
195 enrolled
Unspecified
1 trial
Mechanisms of Dupilumab in AERD
Recruiting
·
S
Scripps Clinic
·
Phase 2
·
NCT05031455
·
16 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for Aspirin Challenge. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Aspirin Challenge compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Aspirin Challenge. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Rush University Medical Center company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 2
[1]
Company
R
Rush University Medical Center
Related News